Daesung Microbiological Labs Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Daesung Microbiological Labs.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?
May 08
Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Mar 15We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability
Feb 17
Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?
Jan 21Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years
Dec 31Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?
Dec 10Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 19In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Daesung Microbiological Labs has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 25,562 | -680 | -2,494 | -1,234 | N/A |
| 9/30/2023 | 25,502 | -674 | -3,098 | -1,686 | N/A |
| 6/30/2023 | 24,796 | 441 | -3,229 | -720 | N/A |
| 3/31/2023 | 24,871 | 127 | -2,748 | -205 | N/A |
| 12/31/2022 | 25,500 | 1,703 | -1,160 | 1,155 | N/A |
| 9/30/2022 | 25,167 | 2,493 | -477 | 2,177 | N/A |
| 6/30/2022 | 25,649 | 2,174 | -542 | 1,694 | N/A |
| 3/31/2022 | 24,760 | 2,568 | -746 | 1,932 | N/A |
| 12/31/2021 | 23,997 | 866 | -766 | 2,203 | N/A |
| 9/30/2021 | 23,179 | -265 | -7,241 | 1,918 | N/A |
| 6/30/2021 | 23,374 | 335 | -8,475 | 2,137 | N/A |
| 3/31/2021 | 23,616 | 766 | -8,909 | 3,580 | N/A |
| 12/31/2020 | 24,801 | 1,519 | -11,208 | 3,236 | N/A |
| 9/30/2020 | 25,408 | 2,058 | -10,396 | 1,920 | N/A |
| 6/30/2020 | 24,515 | 1,882 | -9,465 | 2,926 | N/A |
| 3/31/2020 | 25,868 | 2,510 | -11,187 | 2,876 | N/A |
| 12/31/2019 | 25,134 | 2,471 | -9,259 | 2,315 | N/A |
| 9/30/2019 | 24,918 | 3,566 | -2,297 | 4,441 | N/A |
| 6/30/2019 | 26,544 | 4,255 | -1,146 | 3,410 | N/A |
| 3/31/2019 | 25,483 | 3,622 | 2,506 | 2,897 | N/A |
| 12/31/2018 | 25,097 | 3,170 | 2,640 | 3,136 | N/A |
| 9/30/2018 | 24,159 | 2,098 | 2,143 | 2,739 | N/A |
| 6/30/2018 | 24,088 | 1,654 | 2,556 | 3,896 | N/A |
| 3/31/2018 | 24,151 | 1,686 | 981 | 2,330 | N/A |
| 12/31/2017 | 24,043 | 1,558 | 408 | 1,681 | N/A |
| 9/30/2017 | 26,022 | 2,611 | N/A | 1,548 | N/A |
| 6/30/2017 | 27,353 | 3,089 | N/A | 1,862 | N/A |
| 3/31/2017 | 28,549 | 3,475 | N/A | 2,197 | N/A |
| 12/31/2016 | 30,801 | 4,495 | N/A | 3,521 | N/A |
| 9/30/2016 | 31,805 | 4,583 | N/A | 5,731 | N/A |
| 6/30/2016 | 29,868 | 4,167 | N/A | 5,525 | N/A |
| 3/31/2016 | 31,086 | 4,213 | N/A | 6,346 | N/A |
| 12/31/2015 | 31,026 | 4,550 | N/A | 7,663 | N/A |
| 9/30/2015 | 29,429 | 3,786 | N/A | 4,967 | N/A |
| 6/30/2015 | 30,604 | 3,835 | N/A | 4,863 | N/A |
| 3/31/2015 | 27,902 | 3,293 | N/A | 5,593 | N/A |
| 12/31/2014 | 25,298 | 2,042 | N/A | 3,834 | N/A |
| 9/30/2014 | 24,709 | 1,105 | N/A | 1,872 | N/A |
| 6/30/2014 | 23,747 | 830 | N/A | 2,273 | N/A |
| 3/31/2014 | 22,558 | 624 | N/A | 764 | N/A |
| 12/31/2013 | 21,633 | 433 | N/A | 1,890 | N/A |
| 9/30/2013 | 19,266 | 1,157 | N/A | 3,170 | N/A |
| 6/30/2013 | 16,166 | 464 | N/A | 2,179 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A036480's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if A036480's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A036480's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A036480's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A036480's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A036480's Return on Equity is forecast to be high in 3 years time